Preventra - About the company
Preventra is an unfunded company, founded in 2026. It operates as a Provider of predictive clinical intelligence software for healthcare delivery organizations. Preventra has not raised any funding yet. The company has 1113 active competitors, including 62 funded and 14 that have exited. Its top competitors include companies like Brainomix, Viz.ai and Infervision.
Company Details
Provider of predictive clinical intelligence software for healthcare delivery organizations. This platform integrates with existing electronic health records and care management systems to identify patient risks, such as hospital readmissions and therapy discontinuation. The technology analyzes clinical, claims, and pharmacy data to generate prioritized worklists for care teams. By providing actionable insights and clear clinical rationales, the system supports proactive interventions before adverse outcomes occur. Designed for hospitals, health plans, and physician groups, the software enables clinical teams to track risk, execute care plans, and measure financial performance. The system operates without replacing existing infrastructure or disrupting established clinical workflows.
Key Metrics
Sign up to download Preventra's company profile
Preventra's funding and investors
Preventra has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Preventra's Competitors and alternates
Top competitors of Preventra include Brainomix, Viz.ai and Infervision. Here is the list of Top 10 competitors of Preventra, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Brainomix 2010, Oxford (United Kingdom), Series C | Developer of automated medical imaging software for stroke and lung | $63.3M | 64/100 | |
2nd | Viz.ai 2016, San Francisco (United States), Series D | Developer of an AI-powered platform for care coordination and disease detection | $252M | 62/100 | |
3rd | Infervision 2016, Beijing (China), Series D | AI-based medical imaging and clinical diagnosis solutions | $213M | 59/100 | |
4th | Offers decision support solutions | - | 58/100 | ||
5th | HEALWELL AI 2012, Toronto (Canada), Acquired | AI-enabled decision support tool for healthcare providers | - | 57/100 | |
6th | Surgical Safety 2014, New York City (United States), Series B | Provider of AI-based diagnosis and treatment solutions for healthcare organizations | $33.2M | 55/100 | |
7th | Grand Rounds 2011, San Francisco (United States), Series D | Provider of virtual care, navigation, and support for healthcare needs | $230M | 55/100 | |
8th | Arine 2017, San Francisco (United States), Series C | Medication management solution for healthcare professionals | $95M | 54/100 | |
9th | Xenter 2017, Draper (United States), Series B | Developer of wireless technologies for interventional medicine | $62.2M | 51/100 | |
10th | Predictheon 2019, Barcelona (Spain), Seed | AI-based patient health data analysis software for clinicians | $1.01M | 50/100 | |
1151st | ![]() Preventra 2026, Unfunded | Provider of predictive clinical intelligence software for healthcare delivery organizations | - | - | - |
Looking for more details on Preventra's competitors? Click here to see the top ones
Preventra's Investments and acquisitions
Preventra has made no investments or acquisitions yet.
Reports related to Preventra
Here is the latest report on Preventra's sector:
Are you a Founder ?
FAQs about Preventra
Explore our recently published companies
- GTMMaxing - 2025 founded, Unfunded company
- Guardian Angel Employment - Singapore based, 2026 founded, Unfunded company
- GRW Advisory - 2026 founded, Unfunded company
- Guhan Group - Bengaluru based, 2026 founded, Unfunded company
- Guardiao Azul - Brazil based, 2026 founded, Unfunded company
- GTM Quest - London based, 2024 founded, Unfunded company
